Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Egypt / NCT06839924
Active, not recruiting Not applicable

Effect of Motor Cognitive Interference on Cognition and Quality of Life on Patients with Multiple Sclerosis

NCT06839924 · tracked via the Priya Life Science Egypt tracker
Sponsor
Cairo University
Phase
Not applicable
Started
2024-12-10
Last updated
2025-02-21

Condition(s) studied

Multiple Sclerosis, MS

Investigational drug(s) / intervention(s)

Cognitive Motor Interferencetraditional physical therapy

Cognitive Motor Interference: Dual task that uses cognitive in addition to Motor training

traditional physical therapy: physiotherapy program including exercises in addition to physical modalities

Study summary

Is there an effect of Cognitive Motor Interference on Cognition and quality of life on Multiple Sclerosis patients.

Eligibility

Sex
ALL
Min age
25 Years
Max age
45 Years
Healthy volunteers
No
Inclusion Criteria: 1. M S patients complain of Mild Cognitive impairment according to Modified Mini Mental State (MMSE). 2. Patients with remission and relapse, primary and secondary progression types of MS. 3. Age between 25 and 45 years. 4. Patients from both gender. Exclusion Criteria: 1. patients have visual disorders 2. patients have auditory disturbance 3. Non educational patients. 4. Patients with psychiatric disorders. 5. Patients with mod to severe cognitive impairment according to MMSE

Primary outcome measure(s)

  • Cognition (working memory and divided attention) — baseline assessment and after 12 sessions of Cognitive motor interference 3 sessions per weak for 4 weaks
    cognition domains including working memory and divided attention will be assessed by rehacom V 6.10.2.0 software

Trial sites (1)

FacilityCityRegionStatus
Faculty of Physical Therapy Cairo University Giza Dokki

More Cairo University trials in Egypt

The Link Between Periodontitis, Smoking and Oral Cancer Starting soon
Treating Intrabony Defect With MINST VS MINST Extended PRF Recruiting
Respiratory Exercises Versus Deep Neck Flexor Training in Chronic Mechanical Neck Pain Recruiting
Integrating Aerobic, Respiratory, and Cognitive Training in Acute Heart Failure Starting soon
Preparation Time Of Bioflx Crowns Compared To Zirconia Crowns On Primary Molars Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06839924 on ClinicalTrials.gov ↗ ← All trials in Egypt